W.G. Shaheen & Associates Dba Whitney & CO Vertex Pharmaceuticals Inc Transaction History
W.G. Shaheen & Associates Dba Whitney & CO
- $823 Million
- Q1 2024
A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 50,558 shares of VRTX stock, worth $23.7 Million. This represents 2.57% of its overall portfolio holdings.
Number of Shares
50,558
Previous 50,028
1.06%
Holding current value
$23.7 Million
Previous $20.4 Million
3.82%
% of portfolio
2.57%
Previous 2.66%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,623Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.63 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.33 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...